Bregman Marc 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jul 7, 2021

Insider Transaction Report

Form 4
Period: 2021-05-17
Bregman Marc
CFO, Secretary, Treasurer
Transactions
  • Award

    Options

    2021-05-17$0.06/sh+300,000$16,860300,000 total
    Exercise: $0.06From: 2022-05-17Exp: 2031-05-17Common Stock (300,000 underlying)
Footnotes (2)
  • [F1]Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement.
  • [F2]The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT